InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Wednesday, 12/12/2012 11:13:10 AM

Wednesday, December 12, 2012 11:13:10 AM

Post# of 130507
Shorts need to pick their poison: "Big pharma" development partnership or a buyout.

Either one takes this above .50 share.

Interesting times ahead for the shareholders.

Don't miss the run-up. :)

p.s. This is substantially undervalued at the current share price just based on what we know. The share price should be in the .12-.15 range currently.